Skip to main content
Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.210
+0.070 (6.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.370
+0.160 (13.22%)
Pre-market: Apr 29, 2026, 5:37 AM EDT

Traws Pharma Revenue

In the year 2025, Traws Pharma had annual revenue of $2.79M with 1,134.51% growth.

Revenue (ttm)
$2.79M
Revenue Growth
+1,134.51%
P/S Ratio
4.41
Revenue / Employee
$398,571
Employees
7
Market Cap
12.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.79M2.56M1,134.51%
Dec 31, 2024226.00K--
Dec 31, 2023226.00K--
Dec 31, 2022226.00K--
Dec 31, 2021226.00K-5.00K-2.16%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TRAW News

More News